Literature DB >> 16815222

The cognitive phenotype of Down syndrome: insights from intracellular network analysis.

Avi Ma'ayan1, Katheleen Gardiner, Ravi Iyengar.   

Abstract

Down syndrome (DS) is caused by trisomy of chromosome 21. All individuals with DS exhibit some level of cognitive dysfunction. It is generally accepted that these abnormalities are a result of the upregulation of genes encoded by chromosome 21. Many chromosome 21 proteins are known or predicted to function in critical neurological processes, but typically they function as modulators of these processes, not as key regulators. Thus, upregulation in DS is expected to cause only modest perturbations of normal processes. Systematic approaches such as intracellular network construction and analysis have not been generally applied in DS research. Networks can be assembled from high-throughput experiments or by text-mining of experimental literature. We survey some new developments in constructing such networks, focusing on newly developed network analysis methodologies. We propose how these methods could be integrated with creation and manipulation of mouse models of DS to advance our understanding of the perturbed cell signaling pathways in DS. This understanding could lead to potential therapeutics.

Entities:  

Mesh:

Year:  2006        PMID: 16815222      PMCID: PMC3032589          DOI: 10.1016/j.nurx.2006.05.036

Source DB:  PubMed          Journal:  NeuroRx        ISSN: 1545-5343


  96 in total

1.  An analysis of the class of gene regulatory functions implied by a biochemical model.

Authors:  John Grefenstette; Sohyoung Kim; Stuart Kauffman
Journal:  Biosystems       Date:  2005-12-27       Impact factor: 1.973

Review 2.  From components to regulatory motifs in signalling networks.

Authors:  Avi Ma'ayan; Ravi Iyengar
Journal:  Brief Funct Genomic Proteomic       Date:  2006-02-20

Review 3.  Molecular genetics of addiction vulnerability.

Authors:  George R Uhl
Journal:  NeuroRx       Date:  2006-07

Review 4.  Single cell gene expression profiling in Alzheimer's disease.

Authors:  Stephen D Ginsberg; Shaoli Che; Scott E Counts; Elliott J Mufson
Journal:  NeuroRx       Date:  2006-07

5.  Defective cerebellar response to mitogenic Hedgehog signaling in Down [corrected] syndrome mice.

Authors:  Randall J Roper; Laura L Baxter; Nidhi G Saran; Donna K Klinedinst; Philip A Beachy; Roger H Reeves
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

6.  The proteins of human chromosome 21.

Authors:  Katheleen Gardiner; Alberto C S Costa
Journal:  Am J Med Genet C Semin Med Genet       Date:  2006-08-15       Impact factor: 3.908

7.  Fluoxetine rescues deficient neurogenesis in hippocampus of the Ts65Dn mouse model for Down syndrome.

Authors:  Sarah Clark; Jennifer Schwalbe; Melissa R Stasko; Paul J Yarowsky; Alberto C S Costa
Journal:  Exp Neurol       Date:  2006-04-19       Impact factor: 5.330

8.  A quantitative protein interaction network for the ErbB receptors using protein microarrays.

Authors:  Richard B Jones; Andrew Gordus; Jordan A Krall; Gavin MacBeath
Journal:  Nature       Date:  2005-11-06       Impact factor: 49.962

9.  Target hub proteins serve as master regulators of development in yeast.

Authors:  Anthony R Borneman; Justine A Leigh-Bell; Haiyuan Yu; Paul Bertone; Mark Gerstein; Michael Snyder
Journal:  Genes Dev       Date:  2006-01-31       Impact factor: 11.361

10.  Pathguide: a pathway resource list.

Authors:  Gary D Bader; Michael P Cary; Chris Sander
Journal:  Nucleic Acids Res       Date:  2006-01-01       Impact factor: 16.971

View more
  6 in total

Review 1.  Trisomy 21 and early brain development.

Authors:  Tarik F Haydar; Roger H Reeves
Journal:  Trends Neurosci       Date:  2011-12-09       Impact factor: 13.837

Review 2.  Utility of correlation measures in analysis of gene expression.

Authors:  Anthony Almudevar; Lev B Klebanov; Xing Qiu; Peter Salzman; Andrei Y Yakovlev
Journal:  NeuroRx       Date:  2006-07

Review 3.  The application of NMR-based metabonomics in neurological disorders.

Authors:  Elaine Holmes; Tsz M Tsang; Sarah J Tabrizi
Journal:  NeuroRx       Date:  2006-07

4.  Response abilities of children with Down Syndrome and other intellectual developmental disorders.

Authors:  Pratiksha Tilak Rao; Vasudeva Guddattu; John Michael Solomon
Journal:  Exp Brain Res       Date:  2017-02-24       Impact factor: 1.972

5.  Coat Color-Facilitated Efficient Generation and Analysis of a Mouse Model of Down Syndrome Triplicated for All Human Chromosome 21 Orthologous Regions.

Authors:  Yichen Li; Zhuo Xing; Tao Yu; Annie Pao; Marcel Daadi; Y Eugene Yu
Journal:  Genes (Basel)       Date:  2021-08-06       Impact factor: 4.096

Review 6.  A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome.

Authors:  Frances K Wiseman; Tamara Al-Janabi; John Hardy; Annette Karmiloff-Smith; Dean Nizetic; Victor L J Tybulewicz; Elizabeth M C Fisher; André Strydom
Journal:  Nat Rev Neurosci       Date:  2015-08-05       Impact factor: 34.870

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.